NetworkNewsBreaks

TuesdayApr 29, 2025 10:45 am

NetworkNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Expands International Reach with Juve Stabia Matches on Destination Calcio TV 

Brera Holdings (NASDAQ: BREA) announced that its Italian Serie B squad, S.S. Juve Stabia, will have its next two fixtures streamed live and free in the United States, Canada and United Kingdom via Destination Calcio TV. The matches—against Catanzaro on May 1 and Brescia on May 4—will feature full English commentary and be accessible through the Destination Calcio app and website. Brera Holdings emphasized that expanding Juve Stabia’s global presence aligns with its multi-club ownership strategy and the growing internationalization of football media rights.  To view the full press release, visit https://nnw.fm/ZysW7  About Brera Holdings PLC  Brera Holdings PLC is…

Continue Reading

TuesdayApr 29, 2025 10:39 am

NetworkNewsBreaks – SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Announces 7.2 MW Community Solar Project in Upstate New York 

Disseminated on behalf of SolarBank Corporation  SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) announced plans to develop the Glor Rd project, a 7.2 MW DC ground-mount solar installation in upstate New York. With a secured site lease and an interconnection study underway, the project will operate under New York's VDER rate mechanism and is expected to qualify for NYSERDA NY-Sun Program incentives. Once completed, the project will provide community solar benefits to local residents, offering clean energy access without the need for personal panel installations. Solar Simplified will manage customer-facing activities to support full subscription and maximize revenue.  To…

Continue Reading

TuesdayApr 29, 2025 9:40 am

NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Reports Positive VALID-ECG Study Results Supporting 12-Lead ECG Technology

HeartBeam (NASDAQ: BEAT) announced that its synthesized 12-lead ECG technology met clinical endpoints in the VALID-ECG pivotal study, achieving a 93.4% diagnostic agreement with standard 12-lead ECGs for arrhythmia assessment. Results were presented by Dr. Thomas Deering of Piedmont Heart Institute during the Heart Rhythm Society’s annual conference. HeartBeam’s 3D ECG technology, designed to fit into a credit card-sized device, aims to bring hospital-grade cardiac insights to patients anywhere, with commercialization planned following anticipated FDA clearance. To view the full press release, visit https://nnw.fm/uZWr9 About HeartBeam Inc. HeartBeam is a medical technology company dedicated to transforming cardiac care by providing powerful…

Continue Reading

TuesdayApr 29, 2025 9:10 am

NetworkNewsBreaks – NextPlat Corp (NASDAQ: NXPL) Receives Nasdaq Notice for Minimum Bid Price Noncompliance

NextPlat (NASDAQ: NXPL, NXPLW) announced it has received a written notice from Nasdaq Stock Market LLC stating that the company is not in compliance with Nasdaq Listing Rule 5550(a)(2), as its closing bid price has remained below $1.00 per share for 30 consecutive business days. NextPlat has been granted a 180-calendar day period, until Oct. 27, 2025, to regain compliance by maintaining a minimum $1.00 closing bid price for at least 10 consecutive business days. The company may qualify for an additional 180-day extension if it meets other listing requirements. NextPlat stated it is actively pursuing strategies to improve business efficiency…

Continue Reading

TuesdayApr 29, 2025 9:00 am

NetworkNewsBreaks – Newton Golf Company Inc. (NASDAQ: NWTG) Launches Newton Fast Motion Shaft for Enhanced Swing Speed and Control

Newton Golf Company (NASDAQ: NWTG) announced the launch of its newest shaft family, Newton Fast Motion, now available for purchase at a suggested retail price of $325. The lighter, Tour-proven shaft is engineered to deliver exceptional precision and enhanced swing speed, building on the company’s four core technologies: Elongated Bend Profile, Kinetic Energy Storage, Symmetry 360 Construction and Variable Bend Profile. The Fast Motion series, constructed with advanced high-modulus Toray carbon fibers and featuring a distinctive red-to-gold finish, has already seen adoption by more than 30 professionals across the PGA TOUR Champions and LPGA Tour. Following 887% revenue growth in FY2024,…

Continue Reading

MondayApr 28, 2025 1:25 pm

NetworkNewsBreaks – AirJoule Technologies Corporation (NASDAQ: AIRJ) Secures $15 Million Private Placement Led by GE Vernova

AirJoule Technologies (NASDAQ: AIRJ) announced it has entered into subscription agreements for a $15 million private placement anchored by GE Vernova and other investors to accelerate commercialization of its AirJoule® system, which extracts pure water from air using low-grade waste heat. The net proceeds will fund pilot deployments of the AirJoule® A1000™ units in 2025. AirJoule and GE Vernova also launched a strategic project to integrate the technology into GE Vernova’s product offerings for industrial water production. To view the full article, visit https://nnw.fm/MxHLc About AirJoule Technologies Corporation AirJoule Technologies Corporation (NASDAQ: AIRJ) (formerly Montana Technologies Corporation) is the developer…

Continue Reading

MondayApr 28, 2025 12:29 pm

NetworkNewsBreaks – Brazil Potash Corp. (NYSE-American: GRO) Appoints Marcelo Lessa to Advisory Board 

Brazil Potash (NYSE-American: GRO) announced the appointment of Marcelo Lessa to its advisory board. Lessa, who brings over 30 years of agriculture finance and investment expertise including 16 years at the IFC/World Bank, will support Brazil Potash’s construction financing strategy for its Autazes Project. His extensive experience in securing funding for major agricultural and infrastructure projects is expected to play a key role as the company advances development of its critical mineral potash asset.  To view the full article, visit https://nnw.fm/WJyeQ  About Brazil Potash  Brazil Potash (NYSE-American: GRO) (www.brazilpotash.com) is developing the Autazes Project to supply sustainable fertilizers to one…

Continue Reading

MondayApr 28, 2025 10:15 am

NetworkNewsBreaks – BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXZ) (TSX: BCT) Prices $13.8 Million Public Offering

BriaCell Therapeutics (Nasdaq: BCTX, BCTXZ) (TSX: BCT) announced the pricing of an underwritten public offering of 3,066,666 units at $4.50 per unit for gross proceeds of approximately $13.8 million. Each unit includes one common share or pre-funded warrant and one warrant exercisable at $5.25 per share. The offering, led by ThinkEquity, is expected to close on April 28, 2025, subject to customary conditions. BriaCell plans to use the net proceeds for working capital, corporate purposes and advancing business objectives. To view the full article, visit https://nnw.fm/bi0fN About BriaCell Therapeutics BriaCell is a clinical-stage biotechnology company that develops novel immunotherapies to…

Continue Reading

MondayApr 28, 2025 9:48 am

NetworkNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Showcases ADIO® Technology at NFL Alumni Health Draft Week Event

Datavault AI (NASDAQ: DVLT) highlighted its ADIO® tone technology at NFL Alumni Health’s 16th Annual Draft Week event on April 24, 2025, delivering interactive tones synced with top draft picks and geo-targeted health messages across the venue. The platform enabled real-time fan engagement without screens or manual input and supported cardiovascular health awareness for former athletes. Datavault AI’s deployment demonstrated how AI-powered tone technology can deepen audience interaction and create new monetization opportunities at major live events.  To view the full press release, visit https://nnw.fm/w3D52  About Datavault AI Inc.  Datavault AI (Nasdaq: DVLT) is leading the way in AI experience, valuation,…

Continue Reading

MondayApr 28, 2025 9:31 am

NetworkNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Advances RTNova Platform with IL15 Superagonist Payload

Calidi Biotherapeutics (NYSE American: CLDI) announced the selection of IL15 superagonist (IL15-IL15Ra) as the first therapeutic payload for its systemic antitumor virotherapy platform, RTNova. Preclinical data presented at the AACR Annual Meeting show that Calidi's engineered vaccinia virus can deliver IL15 superagonist directly into the tumor microenvironment, significantly boosting immune response and tumor elimination while minimizing systemic toxicity. The RTNova platform aims to treat metastatic cancers by enabling systemic delivery of tumor-targeted virotherapies.  To view the full press release, visit: https://nnw.fm/m7Yjj  About Calidi Biotherapeutics  Calidi Biotherapeutics specializes in proprietary technology that empowers the immune system to combat cancer. The company’s…

Continue Reading